Metagenomi Therapeutics Inc Revenue per Employee (MGX), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Metagenomi Therapeutics Inc   (NASDAQ: MGX)
 

Metagenomi Therapeutics Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


Metagenomi Therapeutics Inc 's Revenue per employee grew on a trailing twelve month basis to $ 59,546, above the company average.
Within the Healthcare sector Employees of 399 other companies have achieved higher revenue per employee. While Metagenomi Therapeutics Inc 's total ranking has deteriorated compared to the previous quarter from 2726 to 3011. Metagenomi Therapeutics Inc has 119 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

MGX Revenue per Employee (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Revenue Change -74.78 % - -69.76 % -59.32 % -24.8 %
Sales per Employee (TTM) $ 59,546 113,958 187,655 211,849 259,773
MGX's Total Ranking # 3011 # 2726 # 2262 # 1153 #
Seq. Revenue Change - - -68.09 % -54.83 % 1.72 %

MGX Company Profile >> Back to MGX Efficiency Comparisons >> Compare MGX Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 49
Healthcare Sector # 400
Overall Market # 3011

Revenue per Employee Statistics
High Average Low
$ 439,454 $ 268,116 $ 113,958
(Dec 31 2024)   (Jun 30 2026)



Financial Statements
Metagenomi Therapeutics Inc 's Revenue MRQ $ 2 Millions Visit MGX's Income Statement
Metagenomi Therapeutics Inc 's Revenues TTM $ 7 Millions Visit MGX's aggregate revenue growth
What are MGX's Sales? Visit MGX's Sales by Segment




Other Ratios
Metagenomi Therapeutics Inc 's Income per Employee
Employees in Biotechnology & Pharmaceuticals
Biotechnology & Pharmaceuticals Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
MGX's Revenue per Employee versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for MGX's Competitors
Revenue per Employee for MGX's Suppliers
Revenue per Employee for MGX's Customers

You may also want to know
MGX's Sales Growth Rates MGX's Pe Price to earnings ratio MGX's Receivables Turnover Ratio MGX's Stock Quote
MGX's Net Income Growth Rates MGX's Ps Price to Sales ratio MGX's Sales per Employee MGX's Asset Turnover Ratio
MGX's Net Margin MGX's Pb Price to Book ratio MGX's Financial Strength Ratios MGX's Dividend Payout Ratio
Date modified: 2026-11-11T13:51:50+00:00




Companies with similar Revenue per Employee for 12 months ending Sep 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Sep 30 2026Number of Employees Sep 30 2026
Sonoma Pharmaceuticals Inc   93,960.00 $ 23.490  Million 250 
Aclaris Therapeutics Inc   87,684.93 $ 6.401  Million 73 
Biomerica Inc   86,760.00 $ 4.338  Million 50 
Teleflex Incorporated  82,817.74 $ 1,283.675  Million 15,500 
Lenz Therapeutics Inc   81,309.21 $ 12.359  Million 152 
Metagenomi Therapeutics Inc   59,546.22 $ 7.086  Million 119 
Healthcare Services Group Inc   52,218.33 $ 1,879.860  Million 36,000 
Upstream Bio Inc   38,266.67 $ 2.870  Million 75 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.